Camelia-Maria Toma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Camelia-Maria Toma has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Amelia Tero-Vescan
Biochemistry Department, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș, 38th Gh. Marinescu Street, 540139 Târgu Mureş, Romania
1 shared publication - Camil-Eugen Vari
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania
1 shared publication Daniela-Lucia Muntean
Department of Analytical Chemistry and Drug Analysis, Faculty of Pharmacy , George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş , Romania
1 shared publication- Daniela-Lucia Muntean
Department of Analytical Chemistry and Drug Analysis, Faculty of Pharmacy, George Emil Palade University of Medicine and Pharmacy, Sciences and Technology of Târgu Mureș, 540136 Târgu Mureș, Romania
1 shared publication Lénárd Farczádi
Center of Advanced Medical and Pharmaceutical Research , George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures , Romania
1 shared publicationSilvia Imre
Department of Analytical Chemistry and Drug Analysis, Faculty of Pharmacy , George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureş , Romania
1 shared publication
Latest Publications
- Open Access
- 1 December 2023
- Published by George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures in Acta Biologica Marisiensis
- Vol. 6 (2) , 1-10
Comparison of Different Ultrafiltration Devices for the Study of Plasma Protein Binding of Carvedilol
The aim of the present study was to assess the suitability of different Amicon Ultra and Centrifree ultrafiltration devices for the study of the plasma protein binding process in the case of carvedilol, a highly protein-bound and lipophilic beta-blocking agent. Samples at different levels of concentration were prepared in both proteic and non-proteic matrices (human plasma, 5% human serum albumin solution and saline solution) and subjected to the classical ultrafiltration method using the different devices considered. Furthermore, an attempt to apply a previously described modified ultrafiltration method was also made. The analysis and quantification was achieved using a validated LC-MS/MS method. For the Centrifree devices, the determined unbound fractions of carvedilol and the corresponding binding degree were in accordance to literature data, while for the Amicon Ultra devices a great degree of carvedilol adsorbtion to the sample reservoir was observed, the analyte not being detected in the ultrafiltrate samples. Thus, it was further demonstrated that the type of ultrafiltration device used has a significant influence on the outcome of a plasma protein binding study. In the case of carvedilol, the evaluation of the protein binding interaction could be achieved using the Centrifree ultrafiltration devices, but not the Amicon Ultra devices.
- 1 December 2023
- Published by George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures in Acta Biologica Marisiensis
- Vol. 6 (2) , 1-10
Open AccessComparison of Different Ultrafiltration Devices for the Study of Plasma Protein Binding of Carvedilol
The aim of the present study was to assess the suitability of different Amicon Ultra and Centrifree ultrafiltration devices for the study of the plasma protein binding process in the case of carvedilol, a highly protein-bound and lipophilic beta-blocking agent. Samples at different levels of concentration were prepared in both proteic and non-proteic matrices (human plasma, 5% human serum albumin solution and saline solution) and subjected to the classical ultrafiltration method using the different devices considered. Furthermore, an attempt to apply a previously described modified ultrafiltration method was also made. The analysis and quantification was achieved using a validated LC-MS/MS method. For the Centrifree devices, the determined unbound fractions of carvedilol and the corresponding binding degree were in accordance to literature data, while for the Amicon Ultra devices a great degree of carvedilol adsorbtion to the sample reservoir was observed, the analyte not being detected in the ultrafiltrate samples. Thus, it was further demonstrated that the type of ultrafiltration device used has a significant influence on the outcome of a plasma protein binding study. In the case of carvedilol, the evaluation of the protein binding interaction could be achieved using the Centrifree ultrafiltration devices, but not the Amicon Ultra devices.
- Open Access
Ultrafiltration Method for Plasma Protein Binding Studies and Its Limitations
Plasma protein binding plays a critical role in drug therapy, being a key part in the characterization of any compound. Among other methods, this process is largely studied by ultrafiltration based on its advantages. However, the method also has some limitations that could negatively influence the experimental results. The aim of this study was to underline key aspects regarding the limitations of the ultrafiltration method, and the potential ways to overcome them. The main limitations are given by the non-specific binding of the substances, the effect of the volume ratio obtained, and the need of a rigorous control of the experimental conditions, especially pH and temperature. This review presents a variety of methods that can hypothetically reduce the limitations, and concludes that ultrafiltration remains a reliable method for the study of protein binding. However, the methodology of the study should be carefully chosen.
Open AccessUltrafiltration Method for Plasma Protein Binding Studies and Its Limitations
Plasma protein binding plays a critical role in drug therapy, being a key part in the characterization of any compound. Among other methods, this process is largely studied by ultrafiltration based on its advantages. However, the method also has some limitations that could negatively influence the experimental results. The aim of this study was to underline key aspects regarding the limitations of the ultrafiltration method, and the potential ways to overcome them. The main limitations are given by the non-specific binding of the substances, the effect of the volume ratio obtained, and the need of a rigorous control of the experimental conditions, especially pH and temperature. This review presents a variety of methods that can hypothetically reduce the limitations, and concludes that ultrafiltration remains a reliable method for the study of protein binding. However, the methodology of the study should be carefully chosen.